These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Chemical chaperones to the rescue of Alport syndrome? Vanacore RM Kidney Int; 2024 Sep; 106(3):359-361. PubMed ID: 39174196 [TBL] [Abstract][Full Text] [Related]
27. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome. Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752 [TBL] [Abstract][Full Text] [Related]
28. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain. Kang JS; Kashtan CE; Turner AN; Heidet L; Hudson BG; Borza DB J Biol Chem; 2007 Apr; 282(14):10670-7. PubMed ID: 17293596 [TBL] [Abstract][Full Text] [Related]
29. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419 [TBL] [Abstract][Full Text] [Related]
30. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice. Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069 [TBL] [Abstract][Full Text] [Related]
31. Glomerular pathology in Alport syndrome: a molecular perspective. Cosgrove D Pediatr Nephrol; 2012 Jun; 27(6):885-90. PubMed ID: 21455721 [TBL] [Abstract][Full Text] [Related]
32. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Brainwood D; Kashtan C; Gubler MC; Turner AN Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224 [TBL] [Abstract][Full Text] [Related]
33. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Cosgrove D; Kalluri R; Miner JH; Segal Y; Borza DB Kidney Int; 2007 Apr; 71(7):615-8. PubMed ID: 17290292 [TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of glomerular type IV collagen alpha3-5 chain expression in children with thin basement membrane disease. Ueda T; Nakajima M; Akazawa H; Maruhashi Y; Shimoyama H; Sakagami Y; Takagawa K; Kamitsuji H; Naito I; Sado Y; Yoshioka A Nephron; 2002 Oct; 92(2):271-8. PubMed ID: 12218303 [TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy. Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687 [TBL] [Abstract][Full Text] [Related]
36. A novel model of autosomal dominant Alport syndrome in Dalmatian dogs. Hood JC; Huxtable C; Naito I; Smith C; Sinclair R; Savige J Nephrol Dial Transplant; 2002 Dec; 17(12):2094-8. PubMed ID: 12454218 [TBL] [Abstract][Full Text] [Related]
37. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1. Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980 [TBL] [Abstract][Full Text] [Related]
38. Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. Kashtan CE; Kim Y; Lees GE; Thorner PS; Virtanen I; Miner JH J Am Soc Nephrol; 2001 Feb; 12(2):252-260. PubMed ID: 11158215 [TBL] [Abstract][Full Text] [Related]
39. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. Tanaka M; Asada M; Higashi AY; Nakamura J; Oguchi A; Tomita M; Yamada S; Asada N; Takase M; Okuda T; Kawachi H; Economides AN; Robertson E; Takahashi S; Sakurai T; Goldschmeding R; Muso E; Fukatsu A; Kita T; Yanagita M J Clin Invest; 2010 Mar; 120(3):768-77. PubMed ID: 20197625 [TBL] [Abstract][Full Text] [Related]
40. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members. Savige J Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]